Kenneth C. Cundy - Apr 4, 2025 Form 4 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Chief Scientific Officer
Signature
/s/ Kenneth C. Cundy
Stock symbol
ANEB
Transactions as of
Apr 4, 2025
Transactions value $
$0
Form type
4
Date filed
4/7/2025, 09:41 PM
Previous filing
Mar 1, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANEB Stock Option (right to buy) Award $0 +115K $0.00 115K Apr 4, 2025 Common Stock 115K $1.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-sixteenth (1/16) of the shares subject to the option vested and became exercisable on April 4, 2025, with the remainder scheduled to vest and become exercisable in fifteen (15) equal quarterly installments on each July 15, October 15, January 15, and April 15 thereafter, vesting fully on January 15, 2029, in each case, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Remarks:

Exhibit List: Exhibit 24.1 - Power of Attorney (Kenneth C. Cundy)